Anti-Myelin oligodendrocyte glycoprotein 抗体 [EPR4282]
Anti-Myelin oligodendrocyte glycoprotein antibody [EPR4282] - Oligodendrocyte Marker
- RabMAb
- Recombinant
- 詳細を見る
5
(2 Reviews)
|
(2 Publications)
Rabbit Recombinant Monoclonal Myelin oligodendrocyte glycoprotein antibody. Suitable for WB and reacts with Mouse, Rat, Human samples. Cited in 2 publications.
別名を表示する
Myelin-oligodendrocyte glycoprotein, MOG
- WB
Unknown
Western blot - Anti-Myelin oligodendrocyte glycoprotein antibody [EPR4282] - Oligodendrocyte Marker (AB108505)
All lanes:
Western blot - Anti-Myelin oligodendrocyte glycoprotein antibody [EPR4282] - Oligodendrocyte Marker (ab108505) at 1/1000 dilution
Lane 1:
Human brain lysate at 10 µg
Lane 2:
Mouse brain lysate at 10 µg
Lane 3:
Rat brain lysate at 10 µg
Predicted band size: 28 kDa
Observed band size: 28 kDa
false
- WB
Lab
Western blot - Anti-Myelin oligodendrocyte glycoprotein antibody [EPR4282] - Oligodendrocyte Marker (AB108505)
Exposure time : Lane 1-3&5-7 : 20 seconds; Lane 4&8 : 180 seconds
In Western blot analysis, ab109746 exhibited lower sensitivity compared to ab108505 and ab233549, for which reason we recommend the latter two as superior alternatives
Protocol optimizations including increased protein loading (30-50 μg/lane), reduced primary antibody dilution (1 : 500), and fg-grade ECL substrates are suggested if ab109746 must be used.
Lanes 1, 4, 5 and 8:
Western blot - Anti-Myelin oligodendrocyte glycoprotein antibody [EP4281] - Oligodendrocyte Marker (<a href='/products/primary-antibodies/myelin-oligodendrocyte-glycoprotein-antibody-ep4281-oligodendrocyte-marker-ab109746'>ab109746</a>) at 1/1000 dilution
Lanes 2 and 6:
Western blot - Anti-Myelin oligodendrocyte glycoprotein antibody [EPR4282] - Oligodendrocyte Marker (ab108505) at 1/1000 dilution
Lanes 3 and 7:
Western blot - Anti-Myelin oligodendrocyte glycoprotein antibody [EPR22629-310] - Oligodendrocyte Marker (<a href='/products/primary-antibodies/myelin-oligodendrocyte-glycoprotein-antibody-epr22629-310-oligodendrocyte-marker-ab233549'>ab233549</a>) at 1/1000 dilution
Lanes 1 - 4:
Mouse brain tissue lysate at 20 µg
Lanes 5 - 8:
Rat brain tissue lysate at 20 µg
Secondary
All lanes:
Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/20000 dilution
Observed band size: 25 kDa
false
関連する標識済み抗体及び組成の異なる製品 (1)
-
Anti-Myelin oligodendrocyte glycoprotein antibody [EPR4282] - BSA and Azide free
Reactivity data
製品の詳細
Patented technology
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.
What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:
- - High batch-to-batch consistency and reproducibility
- - Improved sensitivity and specificity
- - Long-term security of supply
- - Animal-free batch production
For more information, read more on recombinant antibodies.
出荷温度及び保存条件
製品の状態
バッファー組成
出荷温度
短期保存温度
長期保存温度
保管に関する情報
補足情報
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
MOG influences the immune response and possibly adhesion between myelin membranes. Although it does not form part of a larger well-defined complex it may interact with other myelin-associated proteins to contribute to myelin construction and maintenance. MOG's involvement in these processes supports myelin sheath formation and function aiding electrical conduction in nerve cells. The protein's exposure on the myelin membrane makes it a possible target for immune attacks hinting at its role in autoimmunity.
Pathways
MOG is involved in immune responses and central nervous system pathways. One significant pathway is the autoimmune pathway where MOG can engage with or be targeted by autoimmune antibodies. It interacts with other proteins like myelin basic protein (MBP) in maintaining myelin structures and influencing immunological functions. This interaction implies that disturbances in these pathways might contribute to numerous neurological disorders.
製品プロトコール
- Visit the General protocols
- Visit the Troubleshooting
ターゲットの情報
文献 (2)
Recent publications for all applications. Explore the full list and refine your search
Disease models & mechanisms 17: PubMed38721692
2024
Applications
Unspecified application
Species
Unspecified reactive species
The Journal of biological chemistry 299:102880 PubMed36626984
2023
Applications
Unspecified application
Species
Unspecified reactive species
Abcam product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com